Hrs is a positive regulator of VEGF and insulin signaling

Area of Science:

• Cell biology
• Molecular signaling
• Diabetic retinopathy pathogenesis

Background:

• Vascular endothelial growth factor (VEGF) and insulin are key in diabetic retinopathy.
• Receptor number influences VEGF and insulin action.
• The proteins regulating VEGF-R2 and IR degradation are largely unknown.

Purpose of the Study:

• Investigate the role of Hepatocyte growth factor-Regulated tyrosine kinase Substrate (Hrs) in VEGF and insulin signaling.
• Determine Hrs's impact on VEGF-R2 and IR trafficking and degradation.

Main Methods:

• Ectopic expression of Hrs in cells.
• Analysis of receptor number, tyrosine phosphorylation, and downstream signaling.
• Investigating the role of the Hrs Ubiquitin Interacting Motif (UIM) domain.
• Co-localization and co-immunoprecipitation assays.
• Assessing Hrs's effect on receptor degradation pathways.

Main Results:

• Ectopic Hrs increases VEGF-R2 and IR levels and phosphorylation, amplifying signaling.
• The Hrs UIM domain is crucial for VEGF-R2 but not IR regulation.
• Hrs is tyrosine-phosphorylated upon VEGF and insulin stimulation, with UIM dependence for VEGF.
• Hrs interacts with both VEGF-R2 and IR.
• Hrs inhibits Nedd4-mediated VEGF-R2 degradation.

Conclusions:

• Hrs positively regulates VEGF-R2 and IR signaling.
• Ectopic Hrs expression protects VEGF-R2 and IR from degradation.
• Hrs represents a potential therapeutic target for diabetic retinopathy.